Sprintec
Product Images NDC 67296-0952

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sprintec (NDC 67296-0952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Image (Image 1)

FDA Label Image

1 (Image 2)

1 (Image 2)
This text provides information on several studies related to women's contraceptive use conducted in different years. It includes data on ever use and current use from studies such as the NICHD Women's Contraceptive Study, the French E3N cohort Study, the Shanghai Women's Health Study, The Nurses' Health Study II, the Oxford Family Planning Association Study, and the Danish Sex Hormone Register Study. The text also mentions effect estimates in the form of odds ratios (OR) and relative risks (RR) from certain studies.*
FDA Label Image

Norgestimate Structural Formula (Image 3)

FDA Label Image

Ethinyl Estradiol Structural Formaula (Image 4)

FDA Label Image

Fewer-more Pregnancies Image (Image 5)

Fewer-more Pregnancies Image (Image 5)
This text lists various methods of birth control, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, avoiding sex during fertile days, spermicide, and withdrawal. It provides a comprehensive overview of birth control options for individuals seeking contraception.*
FDA Label Image

Blister Image (Image 6)

FDA Label Image

Image (Image 7)

Image (Image 7)
This is a medication description for norgestimate and ethinyl estradiol tablets USP, with a dosage of 0.250 mg/0.035 mg. Each pack contains 6 blister cards with 28 tablets each. The usual dosage is one tablet daily for 28 consecutive days per menstrual cycle following a specific order of blue and white tablets. The medication should be stored at 20° to 25°C (68° to 77°F) and protected from light. It is important to keep this and all medications out of the reach of children. This product is manufactured by TEVA PHARMACEUTICALS USA, INC. for women's health.*
FDA Label Image

Image (Image 8)

Image (Image 8)
This is a description of a pack of oral contraceptives containing 6 blister cards, each with 28 tablets. The tablets contain norgestimate and ethinyl estradiol in various amounts, meant to prevent pregnancy but do not protect against HIV and other sexually transmitted diseases. Make sure to read the instructions carefully before use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.